Ajit Ramalingam - 01 Sep 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
SVP, Chief Accounting Officer
Signature
/s/ Ajit Ramalingam
Issuer symbol
BIO
Transactions as of
01 Sep 2023
Net transactions value
-$80,104
Form type
4
Filing time
06 Sep 2023, 13:04:25 UTC
Previous filing
07 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +173 +739% $0.000000 196 01 Sep 2023 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability $23,676 -60 -31% $394.60 136 01 Sep 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +169 +124% $0.000000 305 01 Sep 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $23,281 -59 -19% $394.60 246 01 Sep 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +241 +98% $0.000000 487 02 Sep 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $33,146 -84 -17% $394.60 403 02 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -173 -25% $0.000000 521 01 Sep 2023 Bio-Rad A Common Stock 173 $0.000000 Direct F3, F4
transaction BIO Restricted Stock Units Options Exercise $0 -169 -33% $0.000000 338 01 Sep 2023 Bio-Rad A Common Stock 169 $0.000000 Direct F3, F5
transaction BIO Restricted Stock Units Options Exercise $0 -241 -50% $0.000000 241 02 Sep 2023 Bio-Rad A Common Stock 241 $0.000000 Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 23.3950 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2023.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F5 On September 1, 2021, the reporting person was granted 676 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 On September 2, 2020, the reporting person was granted 963 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.